12-4810684-T-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_002235.5(KCNA6):​c.643T>G​(p.Ser215Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

KCNA6
NM_002235.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.670
Variant links:
Genes affected
KCNA6 (HGNC:6225): (potassium voltage-gated channel subfamily A member 6) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class. The coding region of this gene is intronless, and the gene is clustered with genes KCNA1 and KCNA5 on chromosome 12. [provided by RefSeq, Jul 2008]
GALNT8 (HGNC:4130): (polypeptide N-acetylgalactosaminyltransferase 8) This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0617581).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNA6NM_002235.5 linkuse as main transcriptc.643T>G p.Ser215Ala missense_variant 1/1 ENST00000280684.4 NP_002226.1 P17658

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNA6ENST00000280684.4 linkuse as main transcriptc.643T>G p.Ser215Ala missense_variant 1/16 NM_002235.5 ENSP00000280684.3 P17658
GALNT8ENST00000542998.5 linkuse as main transcriptc.310-40054T>G intron_variant 3 ENSP00000440383.1 H0YFU9
ENSG00000256988ENST00000662877.1 linkuse as main transcriptn.409+2872A>C intron_variant
ENSG00000256988ENST00000664363.1 linkuse as main transcriptn.1626+2872A>C intron_variant

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2021The c.643T>G (p.S215A) alteration is located in exon 1 (coding exon 1) of the KCNA6 gene. This alteration results from a T to G substitution at nucleotide position 643, causing the serine (S) at amino acid position 215 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.024
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
13
DANN
Benign
0.56
DEOGEN2
Uncertain
0.42
.;T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.21
.;T
M_CAP
Benign
0.072
D
MetaRNN
Benign
0.062
T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Benign
0.26
.;N
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.33
N;N
REVEL
Benign
0.23
Sift
Benign
0.97
T;T
Sift4G
Benign
0.83
T;T
Polyphen
0.0010
.;B
Vest4
0.085
MutPred
0.41
Gain of catalytic residue at G210 (P = 0.0019);Gain of catalytic residue at G210 (P = 0.0019);
MVP
0.29
MPC
0.90
ClinPred
0.065
T
GERP RS
3.1
Varity_R
0.053
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-4919850; API